Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ewing, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

SEC filing history

Showing 201-225 of 688 matching filings.

Per page
25
Current page
9
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jun 2019
Reporting date
07 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jun 2019
Reporting date
07 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jun 2019
Reporting date
07 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2019
Reporting date
02 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Jun 2019
Reporting date
02 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 May 2019
Reporting date
01 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K FINANCIAL AND OPERATING RESULTS 1Q2019

Filing date
02 May 2019
Reporting date
02 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-32302

DEFA14A

Filing date
29 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-32302

DEF 14A

Filing date
26 Apr 2019
Reporting date
13 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Mar 2019
Reporting date
01 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
05 Mar 2019
Reporting date
01 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K INVESTOR PRESENTATION

Filing date
05 Mar 2019
Reporting date
05 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32302

8-K

Filing date
04 Mar 2019
Reporting date
01 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Feb 2019
Reporting date
26 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .